SCHEMBL22993440

SCHEMBL22993440

Cc1cnc2c(c1)CN(C)CC21COC1

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22993030 0.86 KDM4E (0.35) KDM4E
SCHEMBL22993268 0.80
SCHEMBL24253510 0.80 HTR2A (0.33)
SCHEMBL29388726 0.78 MAOA (0.33)
SCHEMBL25975831 0.77 AVPR1A (0.31)
SCHEMBL22993424 0.76 PDK2 (0.33)
SCHEMBL23416656 0.76
SCHEMBL22993439 0.73 KDM4E (0.38) KDM4E
SCHEMBL23416680 0.71 AVPR1A (0.33)
SCHEMBL24253334 0.69 KDM4E (0.34) KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 WO disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 WO disclosed